Astrazeneca Spain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it has expanded an existing program in Spain to increase access to local testing for homologous recombination deficiency (HRD) throughout the country. The expansion of the program, supported by AstraZeneca Spain and its network throughout the country, will further SOPHiA GENETICS' commitment to global health equity by making this vital testing available to thousands more patients

PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress...

Cytovia Therapeutics, a Florida company with research-and-development operations in Natick, has named a chief financial officer and a chief product officer, as the company advances towards clinical trials and prepares to go public.

For patients with metastatic small-cell lung cancer (SCLC), sparing the hippocampus during prophylactic cranial irradiation (PCI) offered better preservation of cognitive function, but did not necessarily lead to better outcomes in general, such as overall survival (OS) and quality of life (QoL) compared with standard PCI, according to results from the PREMER trial. Still, the phase III study confirms that hippocampal avoidance-PCI (HA-PCI) is still a worthwhile endeavor, as it can be safely delivered, and

(0) CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointments of Luca Scavo as Chief Financial Officer (CFO), effective June 1, 2021, and Julie H. McHugh to its Board of Directors, effective immediately. Mr. Scavo brings more than 25 years of international experience in both emerging and developed markets within pioneering biotechnology and diagnostics companies including Genentech, Roche and AstraZeneca, where he led teams across d...